Medical Condition News

RSS

Emotional stress, cognitive impairment linked to early hospital readmission of heart patients

Heart patients' mental state and thinking abilities may help predict whether costly and potentially dangerous early hospital readmission will follow their release after treatment, according to the results of a significant new study by Henry Ford Hospital researchers.

18 Sep 2013

RedHill Biopharma to initiate phase III trial of RHB 104 in Crohn's disease patients

UCF College of Medicine professor Dr. Saleh Naser soon will participate in a clinical trial to test whether a new antibiotic therapy acquired by RedHill Biopharma can be used to treat Crohn's disease patients.

18 Sep 2013

New prototype technique improves diagnosis of cancer tissue during operation

Tissue-conserving cancer surgery is a highly skilled procedure which involves time-consuming tissue preparation to detect the margins of cancerous tissue. The goal is to remove as much of the tumour as possible while sparing healthy tissue.

18 Sep 2013

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

Researchers at the University of Alberta have developed a synthetic peptide that could be the first in a new class of drugs to treat heart disease, high blood pressure and diabetes.

18 Sep 2013

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

18 Sep 2013

Abnormalities in brain axons predispose people to chronic back pain after injury

Abnormalities in the structure of the brain predispose people to develop chronic pain after a lower back injury, according to new Northwestern Medicine- research. The findings could lead to changes in the way physicians treat patients' pain.

18 Sep 2013

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.

17 Sep 2013

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

Neuroscientist Jonah Chan, PhD, at the University of California, San Francisco, is the first recipient of a new international prize launched to recognize innovation and progress in multiple sclerosis research.

17 Sep 2013

International review shows links between racism and child and youth health outcomes

An international review led by the University of Melbourne has found children and young people experience poor mental health, depression and anxiety following experiences of racism.

17 Sep 2013

Regado Biosciences announces enrollment of first patient in REGULATE-PCI clinical trial

Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.

17 Sep 2013

Women with acute coronary syndrome less likely to have chest pain than men

A higher proportion of women than men 55 years and younger did not have chest pain in acute coronary syndromes (ACS, such as heart attacks or unstable angina), although chest pain was the most common symptom for both sexes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

17 Sep 2013

Boston Scientific announces positive results from REPRISE II clinical trial of Lotus Valve System

Boston Scientific Corporation reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus™ Valve System in symptomatic patients with severe aortic stenosis considered at high risk for surgical valve replacement.

17 Sep 2013

New method to target, eliminate cancer-supporting macrophages in mouse tumors

When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself.

17 Sep 2013

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the prevention of post-operative nausea & vomiting (PONV).

17 Sep 2013

arGEN-X announces CTA filing of Phase Ib cancer study with ARGX-111

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces today the CTA filing of a first-in-man Phase Ib cancer study with ARGX-111, its second proprietary SIMPLE Antibody product to enter the clinic this year.

17 Sep 2013

Research finding offers new approach to treating melanoma

Scientists at Sanford-Burnham Medical Research Institute today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1, plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease.

17 Sep 2013

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.

17 Sep 2013

Spinal injuries present in 11% of Iraq/Afghanistan casualties

Spinal injuries are present in 1 out of 9 U.S. military personnel sustaining combat injuries in Iraq or Afghanistan -- a much higher rate than in previous wars, according to a report in the Sept. 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

17 Sep 2013

Expert offers tips to help college students avoid serious health conditions down the road

To attract customers, restaurant chains have been rolling out budget deals, offering $5 pizzas, $3 meals — even $1 sandwiches. But while these new offerings are light on its customers' wallets, they hit them where it hurts in terms of calories, fat, and sodium content.

17 Sep 2013

New study finds more burnout, depression among physicians who work long hours

Spare a thought for American doctors and their partners: because of long working hours and dedication to their work, they seem to have more squabbles over home and family responsibilities than people in most other professions.

17 Sep 2013

Medical Condition News

Emotional stress, cognitive impairment linked to early hospital readmission of heart patients

RedHill Biopharma to initiate phase III trial of RHB 104 in Crohn's disease patients

New prototype technique improves diagnosis of cancer tissue during operation

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

Abnormalities in brain axons predispose people to chronic back pain after injury

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

International review shows links between racism and child and youth health outcomes

Regado Biosciences announces enrollment of first patient in REGULATE-PCI clinical trial

Women with acute coronary syndrome less likely to have chest pain than men

Boston Scientific announces positive results from REPRISE II clinical trial of Lotus Valve System

New method to target, eliminate cancer-supporting macrophages in mouse tumors

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

arGEN-X announces CTA filing of Phase Ib cancer study with ARGX-111

Research finding offers new approach to treating melanoma

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

Spinal injuries present in 11% of Iraq/Afghanistan casualties

Expert offers tips to help college students avoid serious health conditions down the road

New study finds more burnout, depression among physicians who work long hours

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News